News Focus
News Focus
Post# of 257259
Next 10
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: gfp927z post# 71110

Thursday, 01/08/2009 1:27:51 PM

Thursday, January 08, 2009 1:27:51 PM

Post# of 257259
The preclinical tox issue (intense immune stimulation) have been found with ANA975, a toll-like receptor-7 (TLR-7) agonist. ANA598 is an oral nonnucleoside HCV polymerase inhibitor that binds to a unique site on the HCV NS5b enzyme and has a clean safety profile so far.

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now